SCHEMBL12329336

SCHEMBL12329336

CCc1cccc(CCCCCCC(=O)O)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 1/20 0.66
▸ RXFP1 Q9HBX9 1/20 0.66
▸ PTGFR P43088 1/20 0.55
▸ HDAC3 O15379 1/20 0.55
▸ MAPK1 P28482 1/20 0.55
▸ ADRA1A P35348 1/20 0.55
▸ HDAC4 P56524 1/20 0.55
▸ SLC6A3 Q01959 1/20 0.55
▸ HDAC1 Q13547 1/20 0.55
▸ SMN1; SMN2 Q16637 1/20 0.55
▸ HDAC7 Q8WUI4 1/20 0.55
▸ HDAC2 Q92769 1/20 0.55
▸ HDAC10 Q969S8 1/20 0.55
▸ HDAC11 Q96DB2 1/20 0.55
▸ HDAC8 Q9BY41 1/20 0.55
▸ HDAC6 Q9UBN7 1/20 0.55
▸ HDAC9 Q9UKV0 1/20 0.55
▸ HDAC5 Q9UQL6 1/20 0.55
▸ TBXAS1 P24557 7/20 0.54
▸ LTB4R Q15722 5/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25170050 1.00 MAPT (0.66) MAPTRXFP1PTGFRHDAC3MAPK1
SCHEMBL7512732 0.98 MAPT (0.62) MAPTRXFP1PTGFRHDAC3MAPK1
SCHEMBL10290715 0.93 SMN1; SMN2 (0.63) MAPTRXFP1PTGFRHDAC3MAPK1
SCHEMBL1197247 0.91 MAPT (0.78) MAPTRXFP1HDAC3MAPK1ADRA1A
SCHEMBL711512 0.90 MAPT (0.66) MAPTRXFP1HDAC11PPARGPPARA
SCHEMBL25173309 0.90 MAPT (0.66) MAPTRXFP1HDAC11PPARGPPARA
Hexanoate SCHEMBL28378377 0.89 MAPT (0.64) MAPTRXFP1HDAC11PPARGPPARA
SCHEMBL19248516 0.88 MAPT (0.62) MAPTRXFP1HDAC3MAPK1ADRA1A
SCHEMBL3674500 0.86 KEAP1 (0.61) PTGFRHDAC3MAPK1ADRA1AHDAC4
SCHEMBL27578485 0.85 MAPT (0.68) MAPTRXFP1HDAC3MAPK1ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1954668-B1 HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2011-09-28 — — EP disclosed
Send feedback